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Background:  The Glasgow Prognostic Score (GPS) is a simple inflammation based prognostic score combining C-reactive protein (CRP) 
and albumin and is a strong, well validated prognostic tool in patients with cancer. Although systemic inflammation is a well understood 
cardiovascular risk factor, the prognostic utility of GPS for cardiovascular events is unknown.
methods:  The Glasgow Prognostic Score was measured in 3,600 sequential patients who were undergoing elective diagnostic coronary 
angiography and were followed for major adverse cardiovascular events (MACE, defined as death, myocardial infarction, or stroke) for 
three years. The GPS was determined as: 0, 1, or 2 for none, one, or both of the following: CRP>1.0 mg/dL and albumin<3.5g/dL.
results:  In our study cohort (age 63±11 years, 64% male, 30% diabetic, 71% hypertensive, and 65% smokers), 842 (23%) subjects had 
a GPS=0; 2,608 (72%) subjects had GPS=1; and 150 (4%) subjects had GPS=2 and there were 449 MACE by 3 years. Compared to 
GPS=0, higher GPS scores were incrementally associated with MACE (Figure, GPS=1: HR 2.2, 95% CI 1.6-2.9; and GPS=2: HR 4.4, 95% 
CI 2.9-6.7) and were independent of traditional risk factors (GPS=1: HR 2.0, 95% CI 1.5-2.6; and GPS=2: HR 3.5, 95% CI 2.3-5.4).
Conclusion:  In stable cardiac patients, the simple systemic inflammation-based Glasgow Prognostic score is a robust predictor of MACE. 
These findings underscore the pathologic role of systemic inflammation and nutritional status in cardiovascular disease.
 
